Leinco Technologies awarded a subsidy of USD 1 million to develop a quick test for intestinal resistance to polio

Leinco Technologies, a leader in the field of development of antibodies and proteins, is excited about information that he has received a subsidy of USD 1 million from Gates Foundation. The subsidy aims to develop a quick field test (lateral or similar flow) to assess the intestinal immune response to polyovirus, potentially enabling effective monitoring of vaccination campaigns and quick identification of communities exposed to polio. The availability of such a test can improve the effectiveness of vaccination campaign in high -risk countries.

While the virus has been reduced by more than 99% since the start of the elimination efforts, factors such as uncertainty, humanitarian crisis and inconsistent access to people in motion allowed the virus to continue paralyzing children in some of the most delicate conditions of the planet. If high vaccination indicators in relation to polio are not achieved and maintained, the risk of polio explosions will increase and threaten children even in long -free places. Timely and effective monitoring is a key element of global elimination efforts. The test that Leinco Technologies develops is in line with the strategic goals of the Global Foundation Department of the Foundation, striving to improve the supply of health products with high impact to the poorest communities in the world and expanding access to health insurance.

This subsidy is a transformational opportunity to directly contribute to global public health efforts. “

William Leinert Sr., president and general director of Leinco Technologies

Cooperation is in line with the Leinco mission consisting in the development of research and diagnostics to solve the problem of infectious diseases around the world. Thanks to this subsidy, Leinco will focus on developing a scalable field in the field to ensure that it is possible to observe health organizations and governments ensuring that vaccination campaigns do not leave anyone.

This breakthrough initiative reflects the joint involvement of Leinco Technologies and Gates Foundation in improving health results and eliminating Poloo. When the world is approaching the goal of eliminating, innovative solutions, such as this fast test, play a key role in ensuring success.